We make genomics happen.

Improving health by putting genomic innovation into practice.

We enable partners to translate and implement genomic and digital health technologies into clinical practice, accelerating the potential of precision medicine at scale.

We have 30+ years of expertise in pharmacogenetics. That’s the science that links our genetics to the way we respond to common medicines.

Today, prescriptions are made on a trial-and-error basis as standard, meaning people often receive medicines that don’t work for them, or even cause harmful side effects. We are on a mission to change that.

HI THERE. WE’RE FAVA HEALTH.

We are experts in

Genomics

Digital health

Implementation

How we can help

For health systems

Implementing genomics improves care and outcomes, whilst reducing long-term costs

The main challenge facing genomics is clinical implementation. The pace of innovation has overtaken the capacity of health systems to adapt and accept new scientific discoveries.

We build design-led digital genomic services that are tailored to local contexts aimed at system-wide adoption and population-level impact.

For life sciences

Accelerating the translation of genomic and digital technologies into commercial products

Accessing deep clinical and scientific expertise to guide innovation can be tough. Identifying impactful projects and maximising the likelihood of return is a priority for the life science sector.

We offer bespoke support bringing together expertise across domains to create value for our clients.

For individuals

Improving the safety and effectiveness of medicines through easy at-home genetic testing (beta)

Medicines work well for some people, not at all for a few, and for others can even have harmful side effects. A lot of that is determined by our genes.

We provide access to easy at-home genetic testing in partnership with healthcare providers that will show you how you respond to commonly prescribed medications, improving the likelihood they work for you.

Our Team

  • Headshot of Professor William Newman

    Bill Newman

    MD, PhD, Chief Scientific Officer

    Bill is a consultant clinical geneticist and professor of genomic medicine. Over the past twenty years, he has held a number of national and international leadership roles shaping genomics. He led the first large scale trial of a pharmacogenetic test in the NHS and is committed to widespread adoption of precision medicine for patient benefit.

  • Headshot of Videha Sharma, health innovation expert, CEO of Fava Health

    Videha Sharma

    MD, PhD, Chief Executive Officer

    Videha is a doctor and innovator specialising in digital health and precision medicine. He has a PhD in Health Informatics and completed fellowships in digital health, medical leadership and clinical entrepreneurship. Videha loves to work across different disciplines and push the boundaries of healthcare innovation to improve patient outcomes.

  • Headshot of Dr. John McDermott, clinical geneticists and pharmacogenetics expert

    John McDermott

    MD, Chief Medical Officer

    John is a geneticist specialising in the use of pharmacogenetics in routine practice. He has deep expertise in genomic testing technologies and has led several clinical trials related to personalised medicine. John is an advocate for patient choice and regularly engages communities to ensure Fava design solutions are inclusive and accessible.

  • Headshot of Eliska Collier, brand strategist, chief strategy officer at Fava Health.

    Eliska Collier

    MA (Cantab), Chief Strategy Officer

    Eliska is a brand strategist, UX and brand designer, and a qualified corporate (private equity) lawyer by background. She is a creative problem solver and brings design, commercial and legal expertise to the team. Eliska heads up Fava’s business and marketing strategy.